Breast Cancer

  1. Talzenna (talazoparib)
    Talzenna (talazoparib)
    by Pfizer Europe MA EEIG
    for Breast Cancer
    €0.00
  2. Piqray (alpelisib)
    Piqray (alpelisib)
    by Novartis
    for Breast Cancer
    €22,537.00
  3. Nerlynx (neratinib)
    Nerlynx (neratinib)
    by Puma biotechnology
    for Breast Cancer
    €6,552.47
  4. Verzenio/Verzenios (abemaciclib)
    Verzenio/Verzenios (abemaciclib)
    by Lilly
    for Breast Cancer
    €1,732.80
  5. Ibrance (palbociclib)
    Ibrance (palbociclib)
    by Pfizer Limited
    for Breast Cancer
    €2,780.00
  6. Kisqali (ribociclib)
    Kisqali (ribociclib)
    by Novartis Europharm Limited
    for Breast Cancer
    €2,510.22
  7. Lynparza (olaparib)
    Lynparza (olaparib)
    by AstraZeneca AB
    for Breast Cancer, Gynaecological Cancer
    €6,283.20
  8. Perjeta (pertuzumab)
    Perjeta (pertuzumab)
    by Roche Registration Limited
    for Breast Cancer
    €2,834.58
View as Grid List

8 Items

per page
Set Descending Direction